Literature DB >> 19048256

A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.

Hadim Akoglu1, Gokhan Kadir Atilgan, Ramazan Ozturk, Ezgi Coskun Yenigun, Ipek Isik Gonul, Ali Riza Odabas.   

Abstract

Scleroderma renal crisis (SRC) is a complication of systemic sclerosis characterized by the sudden onset of accelerated arterial hypertension, followed by progressive renal failure. Rarely, patients with SRC may be normotensive on presentation. These patients have poorer prognosis and higher mortality rates than those with hypertensive SRC. This is partly explained by the insidious course of normotensive SRC leading to delayed diagnosis and treatment. Normotensive patients also seem to be less responsive to current treatment modalities. Since available data on etiology, pathogenesis, and risk factors of the disease are inadequate, no effective therapy has been established to date. We report a patient with diffuse cutaneous scleroderma who developed SRC during his hospitalization. The patient remained normotensive and had an insidious course until oliguria and signs of hypervolemia occurred. Etiology, pathogenesis, risk factors, diagnosis, treatment modalities and prognosis of normotensive SRC are also discussed through previously published reports.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048256     DOI: 10.1007/s00296-008-0807-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  37 in total

1.  Systemic sclerosis is not associated with clinical or ambulatory blood pressure.

Authors:  N A Zakopoulos; V Th Kotsis; E J Gialafos; C M Papamichael; V Ch Pitiriga; D N Mitsibounas; M E Mavrikakis
Journal:  Clin Exp Rheumatol       Date:  2003 Mar-Apr       Impact factor: 4.473

Review 2.  Scleroderma renal crisis.

Authors:  Virginia D Steen
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

3.  [Normotensive scleroderma renal crisis].

Authors:  Marcelo Villaverde; Alejandra González; Pablo Orellano; Matías Lafage
Journal:  Medicina (B Aires)       Date:  2003       Impact factor: 0.653

4.  A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment.

Authors:  K Kohno; T Katayama; K Majima; M Fujisawa; S Iida; K Fukami; S Ueda; H Nishida; M Sata; S Kato; M Morimatsu; S Okuda
Journal:  Clin Nephrol       Date:  2000-06       Impact factor: 0.975

5.  Juxtaglomerular hyperplasia and hyperreninemia in progressive systemic sclerosis complicated acute renal failure.

Authors:  R A Stone; C C Tisher; H K Hawkins; R R Robinson
Journal:  Am J Med       Date:  1974-01       Impact factor: 4.965

6.  Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?

Authors:  H Gavras; I Gavras; P J Cannon; H R Brunner; J H Laragh
Journal:  Arch Intern Med       Date:  1977-11

7.  Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.

Authors:  Paul J DeMarco; Michael H Weisman; James R Seibold; Daniel E Furst; Weng Kee Wong; Eric L Hurwitz; Maureen Mayes; Barbara White; Fredrick Wigley; Walter Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Journal:  Arthritis Rheum       Date:  2002-11

8.  Long-term outcomes of scleroderma renal crisis.

Authors:  V D Steen; T A Medsger
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

9.  The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.

Authors:  P J Cannon; M Hassar; D B Case; W J Casarella; S C Sommers; E C LeRoy
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

10.  The kidney in progressive systemic sclerosis: a prospective study.

Authors:  M T Kovalchik; S J Guggenheim; M H Silverman; J S Robertson; J C Steigerwald
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

View more
  5 in total

Review 1.  Scleroderma renal crisis: a review for emergency physicians.

Authors:  Tim Montrief; Alex Koyfman; Brit Long
Journal:  Intern Emerg Med       Date:  2019-05-10       Impact factor: 3.397

Review 2.  The scleroderma kidney: progress in risk factors, therapy, and prevention.

Authors:  Guillaume Bussone; Alice Bérezné; Vincent Pestre; Loïc Guillevin; Luc Mouthon
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

3.  Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-17

4.  Mistaken identity: normotensive scleroderma renal crisis.

Authors:  Arwa Aburizik; Siddharth Singh; Laith Al-Rabadi; Christopher Blosser
Journal:  BMJ Case Rep       Date:  2014-05-29

5.  Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange.

Authors:  Norihiro Nagamura; Seikon Kin
Journal:  Nagoya J Med Sci       Date:  2016-08       Impact factor: 1.131

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.